Literature DB >> 221011

Partial structure of a membrane glycopeptide from virus-transformed hamster cells.

U V Santer, M C Glick.   

Abstract

The predominant surface glycopeptide from a clone of baby hamster kidney cells transformed by Rous sarcoma virus (C13/B4), metabolically labeled with L-[14C]fucose, has been characterized for the first time. This glycopeptide represents 19% of the total radioactivity removed by trypsin from the cell surface of the transformed fibroblasts and is more abundant in the transformed cells than in the normal counterpart. Purification of the glycopeptide after digestion with Pronase was by successive chromatography on DEAE-cellulose and Sephadex G-50. The monosaccharide content of the glycopeptide was 42, 127, 138, 114, and 243 nmol of fucose, sialic acid, galatose, mannose, and glucosamine, respectively. A partial structure of the glycopeptide was proposed from the results of sequential enzymatic degradation coupled with gas-liquid chromatographic analysis of the resultant monosaccharides. All of the enzymes used were purified and pretested on natural substrates and found to remove terminal monosaccharides of the correct configuration, quantitatively. The purification and properties of an alpha-L-fucosidase from rat testes were described. All of the radioactivity in the glycopeptide, recovered as fucose, was present at the core and was removed by treatment with this alpha-L-fucosidase. The proposed structure is a triantennary, completely sialylated, complex glycopeptide containing a core region of beta-D-mannose, beta-D-N-acetylglucosamine, and alpha-L-fucose.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 221011     DOI: 10.1021/bi00579a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  15 in total

1.  The absence of core fucose up-regulates GnT-III and Wnt target genes: a possible mechanism for an adaptive response in terms of glycan function.

Authors:  Ayako Kurimoto; Shinobu Kitazume; Yasuhiko Kizuka; Kazuki Nakajima; Ritsuko Oka; Reiko Fujinawa; Hiroaki Korekane; Yoshiki Yamaguchi; Yoshinao Wada; Naoyuki Taniguchi
Journal:  J Biol Chem       Date:  2014-03-10       Impact factor: 5.157

2.  Investigation of malignancy-related glycopeptides and their release in vitro and in vivo from ascites tumour cells.

Authors:  E Walsh; H Smyth; A Corrigan
Journal:  Ir J Med Sci       Date:  1985-08       Impact factor: 1.568

Review 3.  Terminal glycosylation and disease: influence on cancer and cystic fibrosis.

Authors:  T F Scanlin; M C Glick
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

4.  Induction of N-acetylglucosaminyltransferase V by elevated expression of activated or proto-Ha-ras oncogenes.

Authors:  Y Lu; W Chaney
Journal:  Mol Cell Biochem       Date:  1993-05-12       Impact factor: 3.396

Review 5.  Tumor cell surface carbohydrate and the metastatic phenotype.

Authors:  J W Dennis; S Laferte
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

6.  Increased expression of highly branched N-linked oligosaccharides terminating in N-acetylglucosamine residues in neoplastic and sclerodermal chicken fibroblasts.

Authors:  B E Chechik; B Fernandes
Journal:  Histochem J       Date:  1992-01

7.  O-acetylated sialic acid as a distinct marker for differentiation between several leukemia erythrocytes.

Authors:  G Sen; M Chowdhury; C Mandal
Journal:  Mol Cell Biochem       Date:  1994-07-13       Impact factor: 3.396

8.  [Mechanisms of malignant growth (author's transl)].

Authors:  E Grundmann
Journal:  Klin Wochenschr       Date:  1981-09-01

9.  Both acidic-type and neutral-type asparaginyl-oligosaccharides of host-cell glycoproteins are altered in Rous-sarcoma-virus-transformed chick-embryo fibroblasts.

Authors:  L A Hunt; S E Wright
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

10.  Alterations in fucosyl oligosaccharides of glycoproteins during rat liver regeneration.

Authors:  S Kato; N Akamatsu
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.